King Pharmaceuticals (King) has licensed from Merck Sante, an affiliate of Germany-based Merck KGaA, the exclusive rights to market and sell Cyanokit 5g (hydroxocobalamin for injection) Antidote in
Champions Biotechnology (Champions) has entered into an exclusive licensing agreement with Ramot at Tel Aviv University. The licensing agreement encompasses the development and commercialisation of TAR-1, a single-chain
US Patent and Trademark Office has issued patent to Endocyte covering vitamin receptor binding anti-cancer agents. The patent, entitled “Vitamin Receptor Binding Drug Delivery Conjugates” (US Patent No.
Romaco has presented the vertical heat-sealing machine – Siebler HM 1/230 – for strip-packaging of pharmaceutical solids such as tablets, capsules and effervescent tablets at P-MEC 2009. The
GlaxoSmithKline (GSK) has announced that approximately half a million people will receive its pandemic H1N1 vaccine, Pandemrix, as part of Government initiated vaccination programs across Europe, this week.
Regeneron has received marketing authorisation in the EU for rilonacept, an interleukin-1 blocker, for the treatment of Cryopyrin-Associated Periodic Syndromes (CAPS) with severe symptoms, including Familial Cold Auto-inflammatory
PolyMedix has completed a second clinical study of its anticoagulant reversing agent, PMX-60056. The phase 1B clinical study was a pilot proof-of-concept study conducted in the US under
Pursuant to the terms of the agreement, Sequenom agreed to grant Ibis Biosciences and its affiliates, including Abbott Laboratories, a non-exclusive license under the three mass spectrometry-based patents
Microbix has signed a joint venture agreement with the Hunan Biopharmaceutical (Hunan) to build influenza vaccine production facility, located in Changsha National Biomedical Park near Changsha City, the
The Food and Drug Administration (FDA) has withdrawn a notice of eligibility and call-for-data for safety and effectiveness regarding Saccharomyces boulardii (S. boulardii). In the original notice published
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.